This observational study, called The YOUNG LUNG Study, aims to better understand lung cancer (Non-Small Cell Lung Cancer or Small Cell Lung Carcinoma) in people aged 45 or younger. Researchers want to learn about the causes, risks, and genetic changes associated with lung cancer in this younger age group to improve screening and treatment. You could participate if you were diagnosed with lung cancer at age 45 or younger and are willing to provide medical records, answer two short questionnaires, and give blood and/or saliva samples. The study plans to enroll about 500 people and will collect specimens and data for up to 5 years or until the study closes.

Study design

This is an observational study that aims to enroll about 500 participants. It is not testing a specific drug or treatment.

What's involved

You would provide access to your medical records, answer two short questionnaires, and give up to 5 tubes of blood and/or a saliva sample. You may also consider providing tumor tissue samples.

Compensation

Not stated in the trial record.

Follow-up

Participants will be in this study until it closes or they withdraw consent. The primary endpoint involves collecting specimens and data for up to 5 years or until study closure.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.